OncoMed Makes Board Appointment
This article was originally published in Scrip
OncoMed Pharmaceuticals, Inc. has appointed recently retired CEO of Celgene Cellular Therapeutics, Perry Karsen, to its board of directors. Previously, Karsen was executive vice president and chief operations officer at Celgene Corporation and also served as senior vice president and head of worldwide business development at the company. He has also been CEO of Pearl Therapeutics and held executive positions at Human Genome Sciences, Bristol-Myers Squibb, Genentech and Abbott Laboratories earlier in his career.